Dashyant Dhanak
Chief Tech/Sci/R&D Officer chez DECIPHERA PHARMACEUTICALS, INC.
Fortune : 6 M $ au 31/03/2024
Provenance du réseau au premier degré de Dashyant Dhanak
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 20 | |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ.
8
| Subsidiary | Miscellaneous Commercial Services | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Dashyant Dhanak via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| HERON THERAPEUTICS, INC. | Biotechnology | Sales & Marketing | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| THE SUSTAINABLE NUTRITION GROUP LTD | Agricultural Commodities/Milling | Director/Board Member | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Investment Managers | Private Equity Investor | |
| University of Virginia | College/University | Undergraduate Degree | |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Chief Executive Officer | |
| University of Pennsylvania | College/University | Undergraduate Degree | |
| University of Medicine & Dentistry of New Jersey | College/University | Corporate Officer/Principal | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal | |
| University of Tilburg | College/University | Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
| Louisiana State University | College/University | Doctorate Degree | |
| Purdue University | College/University | Graduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Kansas | College/University | Doctorate Degree Undergraduate Degree | |
| University of New Hampshire | College/University | Doctorate Degree Undergraduate Degree | |
| Robert Wood Johnson Medical School | College/University | Corporate Officer/Principal | |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Treasurer | |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Research!America
 Research!America Miscellaneous Commercial ServicesCommercial Services Research!America is a lobbying firm. The non-profit company is based in Alexandria, VA. The CEO of the company is Mary Woolley. | Miscellaneous Commercial Services | Director/Board Member | |
Yale Cancer Center
 Yale Cancer Center Hospital/Nursing ManagementHealth Services Yale Cancer Center operates as a cancer center. It offers cancer immunology, cancer prevention and control, developmental therapeutics, genomics, genetics and epigenetics, radiobiology and radiotherapy, signal transduction, virus and other infection-associated cancers programs. The company was founded in 1974 and is headquartered in New Haven, CT. | Hospital/Nursing Management | Director/Board Member | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Director/Board Member | |
Covagen AG
 Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Biotechnology | Director/Board Member | |
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member Chairman Founder Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
PeopleFluent, Inc.
 PeopleFluent, Inc. Packaged SoftwareTechnology Services PeopleFluent, Inc. provides Software-as-a-Service talent management solutions. It offers PeopleFluent Mirror Suite that integrates video and social technologies into various talent applications; PeopleFluent Colossus, a data integration cloud service that connects talent data and applications; Recruitment Software, a talent acquisition solution that allows clients to make informed hiring decisions; and Performance Management that allows clients to improve business results, develop employees, and retain key staff. The company was founded by Todd Hayes Loofbourrow in 1997 and is headquartered in Waltham, MA. | Packaged Software | General Counsel | |
| Oncology Clinical Research & Development | Director/Board Member | ||
| Drexel University College of Medicine | College/University | Doctorate Degree | |
| IGNYTA INC | Biotechnology | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| Yale School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Duke University School of Medicine | College/University | Doctorate Degree | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director of Finance/CFO Chief Executive Officer | |
| IGM BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| DARÉ BIOSCIENCE, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Janssen Biotherapeutics | Corporate Officer/Principal Corporate Officer/Principal | ||
Rutgers Cancer Institute of New Jersey
 Rutgers Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services Rutgers Cancer Institute of New Jersey, in partnership with RWJBarnabas Health, is the only National Cancer Institute-designated comprehensive cancer center in New Jersey. Rutgers Cancer Institute has locations in New Brunswick and at University Hospital in Newark, as well as through RWJBarnabas Health facilities. The institute offers advanced cancer treatment options, including bone marrow transplantation, proton therapy, CAR T-cell therapy, and complex surgical procedures. Patients have access to cutting-edge therapies such as precision medicine and immunotherapy, many of which are not widely available. The top cancer researchers and clinicians throughout the state collaborate to apply the latest technologies, therapies, and approaches to improve cancer diagnosis and treatment. | Hospital/Nursing Management | Director/Board Member | |
| BiStro Biotech Consulting LLC | Founder | ||
Janssen Global Services LLC
 Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 44 |
| Suisse | 3 |
| Australie | 2 |
| Pays-Bas | 2 |
| Allemagne | 2 |
Sectorielle
| Health Technology | 21 |
| Consumer Services | 16 |
| Commercial Services | 5 |
| Finance | 4 |
| Health Services | 4 |
Opérationnelle
| Director/Board Member | 85 |
| Corporate Officer/Principal | 73 |
| Independent Dir/Board Member | 37 |
| Chief Tech/Sci/R&D Officer | 27 |
| Undergraduate Degree | 23 |
Relations les plus connectées
| Insiders | |
|---|---|
| Edward Benz | 29 |
| Susan Kelley | 22 |
| James Bristol | 17 |
| Matthew Sherman | 16 |
| Mathai Mammen | 16 |
| Patricia Allen | 14 |
| John R. Martin | 13 |
| William Hait | 13 |
| Rajesh Devraj | 12 |
| Steven Hoerter | 12 |
| Daniel Flynn | 11 |
| Ron Squarer | 10 |
| Tucker Kelly | 10 |
| Robert Friesen | 9 |
| William Strohl | 8 |
- Bourse
- Insiders
- Dashyant Dhanak
- Connexions Sociétés
